Aug 163 minTales from the Battlefield: Frontline Clinical Research in Austere EnvironmentsRubix LS leads the fight against infectious diseases in austere environments, advancing science and saving lives on the front lines.
Mar 45 minStem Cell Clinical Trials in 2024: Risks, Trends, and Success ChancesRegenerating damaged organs, curing chronic diseases, and self-healing abilities are no longer sci-fi. Stem cell therapy is the closest...
Feb 284 minPress ReleaseRubix LS Partners With BioMark To Advance Blood-Based Cancer ScreeningsVancouver, British Columbia – (February 28, 2024) - BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS:...